About Index Trending news
Analyze
Pricing
immuneXcite

immuneXcite

immuneXcite

Biopharmaceuticals ImmuneXcite is a biopharmaceutical company focused on developing the next generation of monoclonal antibodies for cancer, employing....

Elsewhere

Contributors to this profile

Alexa global traffic share

30 Mar 2016
$8,600,000
Venture capital (Series A)
Partners Innovation Fund, Cormorant Asset Management, Sanofi-Genzyme BioVentures

Sanofi Genzyme helps cancer biotech ImmuneXcite close $8.6M financing round

FierceBiotech
+1
30 Mar 2016
$8,600,000
Venture capital (Series A)
Partners Innovation Fund, Cormorant Asset Management, Sanofi-Genzyme BioVentures

ImmuneXcite Completes $8.6M Series A-1 Financing

FinSMEs
+1